Literature DB >> 1360034

Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy.

S J Brecker1, H B Xiao, J Sparrow, D G Gibson.   

Abstract

Mitral or tricuspid regurgitation of long duration may so shorten the ventricular filling time in dilated cardiomyopathy that stroke volume is limited. We assessed the effects of changing the atrioventricular interval during temporary or permanent dual-chamber DDD pacing in twelve dilated cardiomyopathy patients with short ventricular filling times due to regurgitation. We measured ventricular filling time and cardiac output with doppler echocardiography and exercise capacity on a treadmill, at baseline and with the best atrioventricular delay during pacing. The durations of both mitral and tricuspid regurgitation were significantly shorter at the shorter atrioventricular interval (mean reductions 85 [95% CI 60-110] ms and 110 [75-150] ms, respectively; p < 0.001 for both). There were consequent increases in left-ventricular and right-ventricular filling times (65 [35-95] ms and 90 [60-120] ms, p < 0.001). For each 50 ms reduction in atrioventricular delay, left-ventricular filling time increased by 35 ms in six subjects with presystolic mitral regurgitation and right-ventricular filling time by 30 ms in nine subjects with presystolic tricuspid regurgitation. At the short atrioventricular interval, cardiac output was greater than baseline (by 1.1 [0.8-1.4] l/min, p < 0.01) and there were rises in exercise duration (104 [45-165] s, p < 0.05) and maximum oxygen consumption (2.1 [1.5-2.7] ml kg-1 min-1, p < 0.05). There was a decrease in the Likert visual analogue score of breathlessness at peak exercise (8.6 [SD 2.1] vs 4.9 [3.1], p < 0.01). Although from a small sample, these findings suggest that DDD pacing with a short atrioventricular delay may have therapeutic potential in patients with dilated cardiomyopathy, even in the absence of conventional indications for pacemaker implantation.

Entities:  

Mesh:

Year:  1992        PMID: 1360034     DOI: 10.1016/0140-6736(92)92492-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  56 in total

Review 1.  Developing clinical indication for multisite pacing.

Authors:  L Kappenberger; X Lyon; N Cox; G Girod; J Schlaepfer
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

2.  Three dimensional echocardiography documents haemodynamic improvement by biventricular pacing in patients with severe heart failure.

Authors:  W Y Kim; P Søgaard; P T Mortensen; H K Jensen; A K Pedersen; B O Kristensen ; H Egeblad
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

3.  The normal sequence of right and left atrial contraction.

Authors:  G Barletta; R Del Bene; F Fantini
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-07       Impact factor: 1.468

4.  Dual chamber pacing in patients with severe heart failure on beta blocker and amiodarone treatment: preliminary results of a randomised study.

Authors:  H Nägele; R Schomburg; B Petersen; W Rödiger
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

Review 5.  Implantable dual-chamber cardioverter-defibrillator-pacemaker.

Authors:  D Pfeiffer; M Mende; A Hagendorff
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

Review 6.  Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure.

Authors:  S Ellery; L Williams; M Frenneaux
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 7.  Cardiac resynchronisation therapy: when the drugs don't work.

Authors:  R A Bleasdale; M P Frenneaux
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

8.  Repeatability and reproducibility of phase analysis of gated single-photon emission computed tomography myocardial perfusion imaging used to quantify cardiac dyssynchrony.

Authors:  Mark A Trimble; Eric J Velazquez; George L Adams; Emily F Honeycutt; Robert A Pagnanelli; Huiman X Barnhart; Ji Chen; Ami E Iskandrian; Ernest V Garcia; Salvador Borges-Neto
Journal:  Nucl Med Commun       Date:  2008-04       Impact factor: 1.690

Review 9.  Cardiac resynchronization therapy.

Authors:  Silke Isabelle Trautmann; Michael Kloss; Angelo Auricchio
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

10.  Cardiac Resynchronization Therapy for Advanced Heart Failure.

Authors:  Philip B. Adamson; William T. Abraham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.